Functional Strontium Phosphate Coated Magnesium Alloys For ?Orthopaedic Use. This project aims to develop a functional strontium-release surface on magnesium-based orthopaedic implants to suppress the rapid degradation rate of magnesium, facilitate new bone formation and ultimately shorten the healing process. The development of practical, bone-favourable and degradation-inhibiting surfaces for magnesium implants are in demand and can bring significant patient benefits. The project seeks to esta ....Functional Strontium Phosphate Coated Magnesium Alloys For ?Orthopaedic Use. This project aims to develop a functional strontium-release surface on magnesium-based orthopaedic implants to suppress the rapid degradation rate of magnesium, facilitate new bone formation and ultimately shorten the healing process. The development of practical, bone-favourable and degradation-inhibiting surfaces for magnesium implants are in demand and can bring significant patient benefits. The project seeks to establish an understanding of the formation mechanisms of strontium-releasing coatings and determine the critical release rate of strontium to activate bone cell responses.Read moreRead less
Nanoengineered gradient substrata as a novel approach for understanding infection mechanisms. This project will advance our understanding of how bacteria colonise surfaces and will also inform the development of novel antibacterial coatings and diagnostic tools for device-associated infections, which have a significant impact on patients and are a huge burden to the healthcare system.
Nanoengineering of Biomaterial Surfaces to Tailor Innate Immune Responses. The overarching aim of this project is to provide a mechanistic understanding of how surface nanotopography affects inflammatory responses. Recently, we showed that surface nanotopography induced conformational changes in adsorbed proteins can activate or deactivate immune cells. These exciting findings are important because they show that it may be possible to engineer the nanotopography of a biomedical device surface in ....Nanoengineering of Biomaterial Surfaces to Tailor Innate Immune Responses. The overarching aim of this project is to provide a mechanistic understanding of how surface nanotopography affects inflammatory responses. Recently, we showed that surface nanotopography induced conformational changes in adsorbed proteins can activate or deactivate immune cells. These exciting findings are important because they show that it may be possible to engineer the nanotopography of a biomedical device surface in a manner which leads to a desired and predictable level of inflammation. The outcomes of the project will create new fundamental knowledge that in the future can instruct the development of the next generation of biomaterials capable of controlling and directing the body’s inflammatory responses.Read moreRead less
Ultra-low fouling active surfaces. This project aims to develop chemistries and fabrication approaches through innovative materials evaluation to develop ultra-low fouling active electrode surfaces. Development of ultra-low fouling surfaces will have significant impact in a range of applications where system or device failure is attributed to fouling. The growing field of bionics, where implantable electronic devices interface directly with the nervous system, is one such device. The expected ou ....Ultra-low fouling active surfaces. This project aims to develop chemistries and fabrication approaches through innovative materials evaluation to develop ultra-low fouling active electrode surfaces. Development of ultra-low fouling surfaces will have significant impact in a range of applications where system or device failure is attributed to fouling. The growing field of bionics, where implantable electronic devices interface directly with the nervous system, is one such device. The expected outcomes will be an understanding of the material requirements that lead to the elimination of protein and cell accumulation at surfaces that degrades the performance and lifetime of these implants. The findings will benefit any application where fouling is a problem.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE160101308
Funder
Australian Research Council
Funding Amount
$360,000.00
Summary
An in vitro model of biomaterial-induced thrombosis. This project intends to use bioengineering strategies to develop new methods to understand material interactions with proteins and cells. The project plans to develop microfluidic channels to contain test materials and immobilise a key enzyme associated with thrombosis by plasma immersion ion implantation. This knowledge may increase our understanding of material-biomolecule interactions and have implications for manipulating biological foulin ....An in vitro model of biomaterial-induced thrombosis. This project intends to use bioengineering strategies to develop new methods to understand material interactions with proteins and cells. The project plans to develop microfluidic channels to contain test materials and immobilise a key enzyme associated with thrombosis by plasma immersion ion implantation. This knowledge may increase our understanding of material-biomolecule interactions and have implications for manipulating biological fouling across multiple fields.Read moreRead less
Engineering biomaterials that actively promote blood vessel growth. This project aims to improve understanding of the effect of biomaterials on vascular growth & to develop new biomimetic materials using natural polymers silk & gelatin. It expects to generate new knowledge in biomaterials, matrix biology & advanced material processing. Expected outcomes include new knowledge & technological advances in biomaterial-driven vascular growth, porous material manufacture, & proteoglycan-mediated grow ....Engineering biomaterials that actively promote blood vessel growth. This project aims to improve understanding of the effect of biomaterials on vascular growth & to develop new biomimetic materials using natural polymers silk & gelatin. It expects to generate new knowledge in biomaterials, matrix biology & advanced material processing. Expected outcomes include new knowledge & technological advances in biomaterial-driven vascular growth, porous material manufacture, & proteoglycan-mediated growth factor signalling, as well as cross-disciplinary, international collaboration & research training. This should provide significant benefit to Australia’s scholarly output & reputation & long term benefits to biomedical, veterinary, cosmetic, & food industries through new materials & processing technologies. Read moreRead less
Elucidating surface-mediated permissive cues for cellular differentiation. This project will develop a novel biomaterial platform technology that will enable firstly the probing and thereafter the control of the cellular pathways of adult mesenchymal stem cells. These fundamental insights will be translated into novel stem cell culture ware products that will enable clinically relevant, functional tissue repair and regeneration.
Engineering a physiologically-relevant blood vessel in vitro . The project will develop an in vitro blood vessel model which will mimic arterial conditions by incorporating vascular cells and silk conduits as scaffolds, for the first time. This approach will overcome the limitations of simplistic 2D cell cultures, the long maturation times of fully tissue-engineered vessels, and resource intensive animal models. The innovative bioengineered construct proposed builds on the CI’s significant advan ....Engineering a physiologically-relevant blood vessel in vitro . The project will develop an in vitro blood vessel model which will mimic arterial conditions by incorporating vascular cells and silk conduits as scaffolds, for the first time. This approach will overcome the limitations of simplistic 2D cell cultures, the long maturation times of fully tissue-engineered vessels, and resource intensive animal models. The innovative bioengineered construct proposed builds on the CI’s significant advances in materials and surface engineering and the Partner Organisation’s (Codex Research) new bioreactor platform. It will offer a solution for modelling of native vessel processes in vitro that would be more appropriate for pre-clinical drug and device development, and in the long-term, tissue replacement.Read moreRead less